Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 23, 2012, Pages 9167-9172

  Flaisher Grinberg, Shlomit ^a   Persaud, Shawna D ^a   Loh, Horace H ^a   Wei, Li Na ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYC PROTEIN;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN REGION; BRAIN STEM; CHROMATIN; CONTROLLED STUDY; EPIGENETICS; FORCED SWIMMING TEST; GENETIC REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; KAPPA OPIATE RECEPTOR GENE; MOUSE; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REGULATORY RNA SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSORIMOTOR CORTEX; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; EPIGENESIS, GENETIC; MAZE LEARNING; MICE; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, OPIOID, KAPPA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE;

EID: 84861892120     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205565109     Document Type: Article

References (48)

1. Uchida S, et al. (2011) Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 69:359-372.
2. Krishnan V, Nestler EJ (2008) Themolecularneurobiologyofdepression. Nature 455:894-902.
3. Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217-238.
4. Shirayama Y, et al. (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268. (Pubitemid 39167359)
5. Bruchas MR, et al. (2007) Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria. J Neurosci 27(43): 11614-11623. (Pubitemid 350006906)
6. Land BB, et al. (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci USA 106:19168-19173.
7. Land BB, et al. (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28(2):407-414.
8. Bruchas MR, Land BB, Lemos JC, Chavkin C (2009) CRF1-R activation of the dynorphin/ kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS ONE 4:e8528.
9. McLaughlin JP, Marton-Popovici M, Chavkin C (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23(13):5674-5683. (Pubitemid 36807845)
10. McLaughlin JP, Li S, Valdez J, Chavkin TA, Chavkin C (2006) Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system. Neuropsychopharmacology 31(6):1241-1248. (Pubitemid 43971840)
11. Bruchas MR, Land BB, Chavkin C (2010) The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44-55.
12. Carr GV, Lucki I (2010) Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology (Berl) 210:295-302.
13. Wittmann W, et al. (2009) Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34(3):775-785.
14. Knoll AT, et al. (2011) Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70:425-433.
15. Lucas LR, Dragisic T, Duwaerts CC, Swiatkowski M, Suzuki H (2011) Effects of recovery from immobilization stress on striatal preprodynorphin- and kappa opioid receptormRNA levels of the male rat. Physiol Behav 104:972-980.
16. Yukhananov RY, Handa RJ (1996) Alterations in kappa opioid receptor mRNA levels in the paraventricular nucleus of the hypothalamus by stress and sex steroids. Neuroreport 7:1690-1694. (Pubitemid 26332350)
17. Chartoff EH, et al. (2009) Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol 75:704-712.
18. Chen JX, et al. (2004) Changes of mRNA expression of enkephalin and prodynorphin in hippocampus of rats with chronic immobilization stress. World J Gastroenterol 10: 2547-2549.
19. Pearson KA, Stephen A, Beck SG, Valentino RJ (2006) Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in Wistar- Kyoto rats. Neuropsychopharmacology 31(11):2449-2461.
20. Saito M, et al. (2003) Variants of kappa-opioid receptor gene and mRNA in alcoholpreferring and alcohol-avoiding mice. Alcohol 29:39-49. (Pubitemid 36349121)
21. Wei LN, Hu X, Bi J, Loh H (2000) Post-transcriptional regulation of mouse kappaopioid receptor expression. Mol Pharmacol 57:401-408. (Pubitemid 30084518)
22. Yuferov V, et al. (2004) Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14:793-804. (Pubitemid 40054335)
23. Wei LN, Law PY, Loh HH (2004) Post-transcriptional regulation of opioid receptors in the nervous system. Front Biosci 9:1665-1679.
24. Sung B, Loh HH, Wei L (2000) Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury. Neurosci Lett 291:163-166. (Pubitemid 30657917)
25. Chandramohan Y, Droste SK, Arthur JS, Reul JM (2008) The forced swimming-induced behavioural immobility response involves histone H3 phospho-acetylation and c-Fos induction in dentate gyrus granule neurons via activation of the N-methyl-D-aspartate/ extracellular signal-regulated kinase/mitogen- and stress-activated kinase signalling pathway. Eur J Neurosci 27:2701-2713. (Pubitemid 351781672)
26. Park SW, Li J, Loh HH, Wei LN (2002) A novel signaling pathway of nitric oxide on transcriptional regulation of mouse kappa opioid receptor gene. J Neurosci 22(18): 7941-7947. (Pubitemid 35379099)
27. Park SW, Huq MD, Loh HH, Wei LN (2005) Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. J Neurosci 25(13):3350-3357. (Pubitemid 40471343)
28. Park SW, He Y, Ha SG, Loh HH, Wei LN (2008) Epigenetic regulation of kappa opioid receptor gene in neuronal differentiation. Neuroscience 151:1034-1041.
29. Li J, Park SW, Loh HH, Wei LN (2002) Induction of the mouse kappa-opioid receptor gene by retinoic acid in P19 cells. J Biol Chem 277:39967-39972. (Pubitemid 35190984)
30. Salim S, et al. (2011) Potential contribution of oxidative stress and inflammation to anxiety and hypertension. Brain Res 1404:63-71.
31. Hovatta I, Juhila J, Donner J (2010) Oxidative stress in anxiety and comorbid disorders. Neurosci Res 68:261-275.
32. Arruda SF, Siqueira EM, de Valência FF (2009) Vitamin A deficiency increases hepcidin expression and oxidative stress in rat. Nutrition 25:472-478.
33. Bi J, Hu X, Loh HH, Wei LN (2001) Regulation of mouse kappa opioid receptor gene expression by retinoids. J Neurosci 21(5):1590-1599. (Pubitemid 32182199)
34. Tan S, Sagara Y, Liu Y, Maher P, Schubert D (1998) The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141:1423-1432. (Pubitemid 28289917)
35. Bruchas MR, Xu M, Chavkin C (2008) Repeated swim stress induces kappa opioidmediated activation of extracellular signal-regulated kinase 1/2. Neuroreport 19: 1417-1422.
36. Wei LN, Loh HH (2011) Transcriptional and epigenetic regulation of opioid receptor genes: Present and future. Annu Rev Pharmacol Toxicol 51:75-97.
37. Bi J, Hu X, Loh HH, Wei LN (2003) Mouse kappa-opioid receptor mRNA differential transport in neurons. Mol Pharmacol 64:594-599. (Pubitemid 37048562)
38. Shin LM, Liberzon I (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35(1):169-191.
39. Reyes BA, Johnson AD, Glaser JD, Commons KG, Van Bockstaele EJ (2007) Dynorphincontaining axons directly innervate noradrenergic neurons in the rat nucleus locus coeruleus. Neuroscience 145:1077-1086. (Pubitemid 46454355)
40. Herring NR, et al. (2008) Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats. BMC Neurosci 9:49.
41. Simmons ML, Chavkin C (1996) Endogenous opioid regulation of hippocampal function. Int Rev Neurobiol 39:145-196. (Pubitemid 126839973)
42. Kreibich A, et al. (2008) Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: A novel mechanism for regulating the central norepinephrine system. J Neurosci 28(25):6516-6525.
43. Svingos AL, Colago EE (2002) Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex. Brain Res 946:262-271. (Pubitemid 34876339)
44. Timmerman W, Cisci G, Nap A, de Vries JB, Westerink BH (1999) Effects of handling on extracellular levels of glutamate and other amino acids in various areas of the brain measured by microdialysis. Brain Res 833:150-160. (Pubitemid 29333789)
45. Graybeal C, Kiselycznyk C, Holmes A (2012) Stress-induced deficits in cognition and emotionality: A role for glutamate. Curr Top Behav Neurosci, 10.1007/7854-2011-193.
46. Allgaier C, Daschmann B, Sieverling J, Hertting G (1989) Presynaptic kappa-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the alpha 2-adrenoceptors. J Neurochem 53:1629-1635. (Pubitemid 19267035)
47. Kawahara H, Kawahara Y, Westerink BH (2000) The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: A dual-probe microdialysis study in the rat brain. Eur J Pharmacol 387:279-286. (Pubitemid 30067829)
48. Tanaka M, et al. (1989) Met-enkephalin, injected during the early phase of stress, attenuates stress-induced increases in noradrenaline release in rat brain regions. Pharmacol Biochem Behav 32:791-795. (Pubitemid 19162405)